Basecamp Research
Basecamp Research builds biological AI models from genomic data to help design therapeutics, including protein-based medicines.
$140MSeries C
ParticipantTV
True Ventures
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026
True Ventures leads pre-seed and seed rounds, usually as a company’s first institutional investor, across software, AI, biology, hardware, consumer products, robotics, energy and defence.
It invests while a business may still be an idea or a small team testing a hypothesis. The partnership works collectively: no individual partner owns a deal, and founders can draw on the wider team from the first meeting.
Its founder network supplies practical introductions to early customers, candidates and other entrepreneurs. The firm has also backed founders in their subsequent companies, making repeat company building part of its investment model.
Sources
- Rounds participated in
- 4
- Confirmed lead rounds
- 0 2 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $459M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionEnveda
Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.
$311MSeries E
ParticipantPatina
Discovers new scent molecules for fragrance and flavor industries using ML-based olfactory modeling
$2MSeed
Role not disclosedPraxisPro
Provides AI-powered commercial intelligence for Life Sciences organizations
$6MSeed
Role not disclosed